Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action
November 21, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that new analyses...
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 21, 2024 07:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
Pharmaceuticals ICT Market Set to Surpass $79 Billion by 2028, Driven by Rising Budgets and Advanced Technology Adoption
November 21, 2024 04:17 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceuticals - Enterprise ICT" report has been added to ResearchAndMarkets.com's offering.The Pharmaceuticals Enterprise ICT report summarizes key...
Trends in the $6 Billion Botanical Drugs Industry, 2030: An Assessment of Emerging Growth Opportunities and Strategic Developments
November 20, 2024 11:12 ET
|
Research and Markets
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030" report has...
Endocrinology Drugs Market Analysis by Therapy Area, Distribution Channel and Region - A Forecasted $53.85 Billion Industry by 2030
November 20, 2024 10:59 ET
|
Research and Markets
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Endocrinology Drugs Market by Therapy Area, Distribution Channel - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2024
November 20, 2024 08:11 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - October 2024
November 20, 2024 08:11 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
November 20, 2024 07:00 ET
|
Avextra AG
Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis varieties with specific, consistent and reproducible cannabinoid and terpene profiles.Over a two-year...
Lemon Bioflavonoids Market Projected to Grow Significantly, Reaching US$ 663.5 Million by 2034 | Fact.MR Report
November 19, 2024 08:00 ET
|
FACT.MR
Rockville, MD, Nov. 19, 2024 (GLOBE NEWSWIRE) -- According to a newly published report by Fact.MR, a market research and competitive intelligence provider, the global lemon bioflavonoids market is...
Aclaris Therapeutics Announces $80 Million Private Placement
November 18, 2024 08:10 ET
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Announces $80 Million Private Placement